WO2025052303 - CIRCULAR RNA AND PREPARATION METHODS THEREOF
National phase entry:
Publication Number
WO/2025/052303
Publication Date
13.03.2025
International Application No.
PCT/IB2024/058665
International Filing Date
05.09.2024
Title **
[English]
CIRCULAR RNA AND PREPARATION METHODS THEREOF
[French]
ARN CIRCULAIRE ET PROCÉDÉS DE PRÉPARATION ASSOCIÉS
Applicants **
BEONE MEDICINES I GMBH
BEONE GUANGZHOU BIOLOGICS MANUFACTURING CO., LTD.
Inventors
LIN, Jiao
LU, Yu
Priority Data
PCT/CN2023/117650
08.09.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3558 | |
| EPO | Filing, Examination, Granting | 27226 | |
| Japan | Filing, Examination, Granting | 3338 | |
| South Korea | Filing, Examination, Granting | 4738 | |
| USA | Filing, Examination, Granting | 13140 |

Total:
52,000
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Compositions and methods for efficiently constructing circular RNA are described. In particular, described are trans-splicing methods involving multiple fragments of Group I intron or derivatives thereof for efficient production of circular RNA with substantially no side products of dimer or concatemer. Also described are compositions related to the methods.[French]
L'invention concerne des compositions et des procédés de construction efficace d'ARN circulaire. En particulier, l'invention concerne des procédés de trans-épissage impliquant de multiples fragments d'intron du groupe I ou des dérivés de ceux-ci pour une production efficace d'ARN circulaire avec sensiblement aucun produit secondaire de dimère ou de concatémère. L'invention concerne également des compositions associées aux procédés.